Kaletra ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
93Primary biliary cholangitis1

93. Primary biliary cholangitis


Clinical trials : 298 Drugs : 252 - (DrugBank : 59) / Drug target genes : 35 - Drug target pathways : 115
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01614405
(ClinicalTrials.gov)
June 201225/4/2011Highly Active Antiretroviral Therapy for Patients With Primary Biliary CirrhosisRandomized Controlled Pilot Study of Highly Active Anti-Retroviral Therapy for Patients With Primary Biliary CirrhosisPrimary Biliary CirrhosisDrug: Truvada and KaletraUniversity of AlbertaAbbott;Gilead Sciences;Canadian Institutes of Health Research (CIHR)Completed18 YearsN/ABoth13N/ACanada